European Monitoring Centre for Drugs and Drug Addiction
Supervised drug consumption facilities, where illicit drugs can be used under the supervision of trained staff, have been operating in Europe for the last three decades. These facilities primarily aim to reduce the acute risks of disease transmission through unhygienic injecting, prevent drug-...
Tags: Health care professionals, NGOs, People who use drugs (PUD), Policy makers, Central Europe, Northern Europe, Southern Europe, Western Europe, Care and support, Harm reduction, Prevention
European Monitoring Centre for Drugs and Drug Addiction
Methamphetamine is an established stimulant drug in many parts of the world (e.g. South-east Asia, US), where it has long caused major public health problems. While methamphetamine use in Europe has historically been confined to the Czech Republic and Slovakia, new pockets and patterns of use...
Tags: Health care professionals, NGOs, People who use drugs (PUD), Policy makers, Central Europe, Eastern Europe, Southern Europe, Western Europe, Care and support, Harm reduction, Prevention, Social issues
European Monitoring Centre for Drugs and Drug Addiction
Transmitted through the sharing of needles, syringes and other injecting equipment, hepatitis C is the most common infectious disease among injecting drug users in Europe today.In this analysis, the EMCDDA looks at some of the positive advances in treating the disease, including a new generation...
Tags: Health care professionals, People who use drugs (PUD), Policy makers, Central Europe, Northern Europe, Southern Europe, Western Europe, Care and support, Harm reduction, Prevention, Treatment, Viral hepatitis
European Monitoring Centre for Drugs and Drug Addiction
It is estimated that over 70 000 lives were lost to drug overdoses in Europe in the first decade of the 21st Century. Reducing drug-related deaths, therefore, remains a major challenge for public health policy. This analysis describes some of the factors that increase the risk of fatal and non-...
Tags: General public, Health care professionals, NGOs, People living with HIV (PLHIV), People who are/were in prisons, People who use drugs (PUD), Policy makers, Central Europe, Northern Europe, Southern Europe, Western Europe, Care and support, Harm reduction, Prevention
The Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) addresses existing gaps in the prevention of HIV and other co-infections, especially tuberculosis (TB) and viral hepatitis, among people who inject drugs (PWID). This three-year project was launched in late 2015...
This report is part of the European Union co-funded project “Improving Prison Conditions by Strengthening Infectious Disease Monitoring”, led by Harm Reduction International. The project aims to reduce ill treatment of people in detention and improve prison conditions through more comprehensive...
Tags: General public, Health care professionals, People who are/were in prisons, Policy makers, Central Europe, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Harm reduction, Human rights, Laws and regulations, Monitoring and Evaluation, Treatment, Tubercolosis
Helene Reemann, Dr. Ulrich Laukam m-Josten, Martine van der Meulen
IQhiv is an initiative of civil society, government, academic and international organizations investigating quality assurance and quality improvement practices relevant to HIV prevention programs and projects across Europe. In 2008, WHO Europe and the Federal Centre for Health Education (BZgA)...
Tags: Health care professionals, NGOs, Policy makers, Central Europe, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Advocacy, Quality development and assurance
